Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

被引：0

作者：

Thorsten O. Götze

Pompiliu Piso

Sylvie Lorenzen

Ulli S. Bankstahl

Claudia Pauligk

Moustafa Elshafei

Giuseppe Amato

Daniel Reim

Wolf O. Bechstein

Alfred Königsrainer

Stefan P. Mönig

Beate Rau

Matthias Schwarzbach

Salah-Eddin Al-Batran

机构：

[1] Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest,Department for General and Visceral Surgery

[2] UCT-University Cancer Center,Third Department of Internal Medicine (Hematology/Medical Oncology), Klinikum Rechts der Isar

[3] Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest,Department of General Surgery and Emergency

[4] Hospital Barmherzige Brueder,Klinik und Poliklinik für Chirurgie, Klinikum rechts der Isar

[5] University of Regensburg,Department of General and Visceral Surgery

[6] Technische Universitat Munchen,Department of General

[7] Bariatrische und Metabolische Chirurgie,, Visceral Surgery and Transplantation

[8] Krankenhaus Nordwest,Service de Chirurgie viscérale

[9] University of Palermo,Department of Surgery

[10] Technische Universität München,undefined

[11] University Hospital Frankfurt,undefined

[12] University Hospital Tübingen,undefined

[13] Hôpitaux Universitaires de Genève,undefined

[14] Campus Charité Mitte,undefined

[15] Campus Virchow-Klinikum CCM/CVK,undefined

[16] Clinic for General,undefined

[17] Visceral,undefined

[18] Vascular and Thoracic Surgery,undefined

[19] Klinikum Frankfurt Höchst,undefined

来源：

BMC Cancer | / 21卷

关键词：

Gastric cancer; Gastroesophageal junction cancer; Lauren- classification; Signet ring cells; HIPEC; Hyperthermic intraperitoneal chemotherapy; FLOT- regimen; Gastrectomy; Quality of life; Cisplatin; Peritoneal carcinomatosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 4 条

[1] Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"-(FLOT9) trial of the AIO/CAOGI /ACO
Goetze, Thorsten O.
Piso, Pompiliu
Lorenzen, Sylvie
Bankstahl, Ulli S.
Pauligk, Claudia
Elshafei, Moustafa
Amato, Giuseppe
Reim, Daniel
Bechstein, Wolf O.
Koenigsrainer, Alfred
Moenig, Stefan P.
Rau, Beate
Schwarzbach, Matthias
Al-Batran, Salah-Eddin
BMC CANCER, 2021, 21 (01)
[2] Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Goetze, Thorsten O.
Hofheinz, Ralf-Dieter
Gaiser, Timo
Schmalenberg, Harald
Strumberg, Dirk
Goekkurt, Eray
Angermeier, Stefan
Zander, Thomas
Kopp, Hans G.
Pink, Daniel
Siegler, Gabriele
Schenk, Michael
de Vita, Ferdinando
Galizia, Gennaro
Maiello, Evaristo
Bechstein, Wolf O.
Elshafei, Moustafa
Loose, Maria
Sookthai, Disorn
Brulin, Tanita
Pauligk, Claudia
Homann, Nils
Al-Batran, Salah-Eddin
INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (01) : 153 - 163
[3] The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI
Al-Batran, Salah-Eddin
Goetze, Thorsten O.
Mueller, Daniel W.
Vogel, Arndt
Winkler, Michael
Lorenzen, Sylvie
Novotny, Alexander
Pauligk, Claudia
Homann, Nils
Jungbluth, Thomas
Reissfelder, Christoph
Caca, Karel
Retter, Steffen
Horndasch, Eva
Gumpp, Julia
Bolling, Claus
Fuchs, Karl-Hermann
Blau, Wolfgang
Padberg, Winfried
Pohl, Michael
Wunsch, Andreas
Michl, Patrick
Mannes, Frank
Schwarzbach, Matthias
Schmalenberg, Harald
Hohaus, Michael
Scholz, Christian
Benckert, Christoph
Knorrenschild, Jorge Riera
Kanngiesser, Veit
Zander, Thomas
Alakus, Hakan
Hofheinz, Ralf-Dieter
Roedel, Claus
Shah, Manish A.
Sasako, Mitsuru
Lorenz, Dietmar
Izbicki, Jakob
Bechstein, Wolf O.
Lang, Hauke
Moenig, Stefan P.
BMC CANCER, 2017, 17
[4] The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI
Salah-Eddin Al-Batran
Thorsten O. Goetze
Daniel W. Mueller
Arndt Vogel
Michael Winkler
Sylvie Lorenzen
Alexander Novotny
Claudia Pauligk
Nils Homann
Thomas Jungbluth
Christoph Reissfelder
Karel Caca
Steffen Retter
Eva Horndasch
Julia Gumpp
Claus Bolling
Karl-Hermann Fuchs
Wolfgang Blau
Winfried Padberg
Michael Pohl
Andreas Wunsch
Patrick Michl
Frank Mannes
Matthias Schwarzbach
Harald Schmalenberg
Michael Hohaus
Christian Scholz
Christoph Benckert
Jorge Riera Knorrenschild
Veit Kanngießer
Thomas Zander
Hakan Alakus
Ralf-Dieter Hofheinz
Claus Roedel
Manish A. Shah
Mitsuru Sasako
Dietmar Lorenz
Jakob Izbicki
Wolf O. Bechstein
Hauke Lang
Stefan P. Moenig
BMC Cancer, 17

← 1 →